State Street Corp Agios Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,331,433 shares of AGIO stock, worth $137 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,331,433

Previous 2,114,949 10.24%

Holding current value

$137 Million

Previous $91.2 Million 13.59%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $8.92 Million - $10.8 Million	216,484 Added 10.24%	2,331,433 $104 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $28.2 Million - $50 Million	-1,023,248 Reduced 32.61%	2,114,949 $91.2 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $10.9 Million - $17.8 Million	512,512 Added 19.52%	3,138,197 $91.8 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $7.23 Million - $8.88 Million	361,851 Added 15.98%	2,625,685 $58.5 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $7.74 Million - $8.95 Million	-317,635 Reduced 12.3%	2,263,834 $56 Million
Q2 2023 Aug 14, 2023	SELL	$21.38 - $29.19 $10.3 Million - $14.1 Million	-482,533 Reduced 15.75%	2,581,469 $73.1 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $2.5 Million - $3.56 Million	-115,066 Reduced 3.62%	3,064,002 $70.4 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $13.5 Million - $17.2 Million	544,296 Added 20.66%	3,179,068 $89.3 Million
Q3 2022 Nov 15, 2022	SELL	$19.51 - $34.14 $15 Million - $26.2 Million	-766,447 Reduced 22.53%	2,634,772 $74.5 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $3.66 Million - $6.75 Million	214,706 Added 6.74%	3,401,219 $75.4 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $5.17 Million - $6.74 Million	193,631 Added 6.47%	3,186,513 $92.8 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $17.7 Million - $29.9 Million	599,992 Added 25.07%	2,992,882 $98.4 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $17.7 Million - $24.6 Million	422,831 Added 21.46%	2,392,890 $110 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $12.4 Million - $14.5 Million	237,469 Added 13.71%	1,970,059 $109 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $39.4 Million - $51.2 Million	-889,691 Reduced 33.93%	1,732,590 $89.5 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $18.4 Million - $25.8 Million	555,259 Added 26.86%	2,622,281 $114 Million
Q3 2020 Nov 10, 2020	BUY	$33.87 - $55.93 $5.84 Million - $9.64 Million	172,394 Added 9.1%	2,067,022 $72.3 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $505,760 - $785,139	-14,681 Reduced 0.77%	1,894,628 $101 Million
Q1 2020 May 11, 2020	BUY	$31.52 - $53.81 $60.2 Million - $103 Million	1,909,309 New	1,909,309 $67.7 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.23B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Agios Pharmaceuticals, Inc. Transaction History